Cipla Limited (BOM:500087)
India · Delayed Price · Currency is INR 1,371.55
+2.00 (0.15%)
At close: Jan 22, 2026
Cipla Market Cap
Cipla has a market cap or net worth of 1.11 trillion as of January 23, 2026. Its market cap has decreased by -9.30% in one year.
Market Cap
1.11T
Enterprise Value
1.01T
Revenue
279.66B
Ranking
n/a
PE Ratio
20.34
Stock Price
1,371.55
Market Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.11T, an increase of 73,030.01%. That is a compound annual growth rate of 24.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 1.11T | -9.32% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.87% |
| Dec 30, 2022 | 868.37B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.35T |
| Lupin | 977.28B |
| Dr. Reddy's Laboratories | 961.99B |
| Abbott India | 586.58B |
| GlaxoSmithKline Pharmaceuticals | 385.24B |
| J. B. Chemicals & Pharmaceuticals | 295.25B |
| AstraZeneca Pharma India | 206.31B |
| Jubilant Pharmova | 150.20B |